{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:44:16Z","timestamp":1790790256155,"version":"4.1.0"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T00:00:00Z","timestamp":1712275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\">\n<jats:title>Background<\/jats:title>\n<jats:p>Atrial arrhythmias (AA) commonly affect patients with cardiac amyloidosis (CA) and are a contributing risk factor for the development of heart failure (HF). This study sought to investigate the long-term efficacy and impact of catheter ablation on HF progression in patients with CA and AA.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec002\">\n<jats:title>Methods<\/jats:title>\n<jats:p>Thirty-one patients with CA and AA undergoing catheter ablation were retrospectively included (transthyretin\u2014ATTR CA 61% and light chain\u2014AL CA 39%). AA subtypes included atrial fibrillation (AFib) in 22 (paroxysmal in 10 and persistent in 12), atrial flutter (AFl) in 17 and atrial tachycardia (AT) in 11 patients. Long-term AA recurrence rates were evaluated along with the impact of sinus rhythm (SR) maintenance on HF and mortality.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec003\">\n<jats:title>Results<\/jats:title>\n<jats:p>AA recurrence was observed in 14 patients (45%) at a median of 3.5 months (AFib n = 8, AT n = 6, AFl = 0). Post-cardioversion, medical therapy or catheter ablation, 10 patients (32%) remained in permanent AA. Over a median follow-up of 19 months, all-cause mortality was 39% (n = 12): 3 with end-stage HF, 5 due to late complications of CA, 1 sudden cardiac death, 1 stroke, 1 COVID 19 (and one unknown). With maintenance of SR following catheter ablation, significant reductions in serum creatinine and natriuretic peptide levels were observed with improvements in NYHA class. Two patients required hospitalization for HF in the SR maintenance cohort compared to 5 patients in the AA recurrence cohort (p = 0.1). All 3 patients with deaths secondary to HF had AA recurrence compared to 11 out of the 28 patients whom were long-term survivors or deaths not related to HF (p = 0.04). All-cause mortality was not associated with AA recurrence.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"sec004\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>This study demonstrates moderate long-term efficacy of SR maintenance with catheter ablation for AA in patients with CA. Improvements in clinical and biological status with positive trends in HF mortality are observed if SR can be maintained.<\/jats:p>\n<\/jats:sec>","DOI":"10.1371\/journal.pone.0301753","type":"journal-article","created":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:16:06Z","timestamp":1712333766000},"page":"e0301753","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":16,"title":["Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4800-1841","authenticated-orcid":true,"given":"Philippe","family":"Maury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sanchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Djouadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3751-6524","authenticated-orcid":true,"given":"Hubert","family":"Delasnerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1280-7042","authenticated-orcid":true,"given":"Serge","family":"Boveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Fournier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Itier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Mondoly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quentin","family":"Voglimacci-Stephanopoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9897-6807","authenticated-orcid":true,"given":"Maxime","family":"Beneyto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarvinder S.","family":"Dhanjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Rollin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thibaud","family":"Damy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Lairez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Lellouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2024,4,5]]},"reference":[{"key":"pone.0301753.ref001","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2014.165","article-title":"Pathophysiology and treatment of cardiac amyloidosis.","volume":"12","author":"MA Gertz","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"pone.0301753.ref002","first-page":"3051","article-title":"Arrhythmias in Cardiac Amyloidosis.","volume":"9","author":"MJ Roy","year":"2018","journal-title":"J Innov Cardiac Rhythm Manag"},{"key":"pone.0301753.ref003","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1080\/13506129.2018.1430027","article-title":"Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis","volume":"25","author":"MY Henein","year":"2018","journal-title":"Amyloid"},{"key":"pone.0301753.ref004","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jacc.2018.10.079","article-title":"Direct Current Cardioversion of Atrial Arrhythmias in Adults With Cardiac Amyloidosis","volume":"73","author":"EA El-Am","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"pone.0301753.ref005","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0033-0620(90)90017-V","article-title":"Clinical evaluation of left ventricular diastolic performance.","volume":"32","author":"WC Little","year":"1990","journal-title":"Prog Cardiovasc Dis"},{"key":"pone.0301753.ref006","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of Arrhythmias in Cardiac Amyloidosis.","volume":"6","author":"S Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"pone.0301753.ref007","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/13506129.2015.1028616","article-title":"Atrial fibrillation in amyloidotic cardiomyopathy: prevalence, incidence, risk factors and prognostic role","volume":"22","author":"S Longhi","year":"2015","journal-title":"Amyloid"},{"key":"pone.0301753.ref008","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ehf2.12308","article-title":"Features of atrial fibrillation in wild-type transthyretin cardiac amyloidosis: a systematic review and clinical experience","volume":"5","author":"YY Mints","year":"2018","journal-title":"ESC Heart Fail"},{"key":"pone.0301753.ref009","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1080\/13506129.2019.1620724","article-title":"Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality","volume":"26","author":"K Sanchis","year":"2019","journal-title":"Amyloid"},{"key":"pone.0301753.ref010","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jacep.2020.04.019","article-title":"Atrial Fibrillation in Transthyretin Cardiac Amyloidosis. Predictors, Prevalence, and Efficacy of Rhythm Control Strategies","volume":"6","author":"E Donnellan","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"pone.0301753.ref011","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1056\/NEJMoa041018","article-title":"Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure","volume":"351","author":"LF Hsu","year":"2004","journal-title":"N Engl J Med"},{"key":"pone.0301753.ref012","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1161\/CIRCULATIONAHA.115.019406","article-title":"Results From the AATAC Multicenter Randomized Trial. Ablation vs. amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device","volume":"133","author":"L Di Biase","year":"2016","journal-title":"Circulation"},{"key":"pone.0301753.ref013","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1707855","article-title":"Catheter Ablation for Atrial Fibrillation with Heart Failure","volume":"378","author":"NF Marrouche","year":"2018","journal-title":"N Engl J Med"},{"key":"pone.0301753.ref014","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.hrthm.2015.09.016","article-title":"Electrophysiologic assessment of conduction abnormalities and atrial arrhythmias associated with amyloid cardiomyopathy","volume":"13","author":"CR Barbhaiya","year":"2016","journal-title":"Heart Rhythm"},{"key":"pone.0301753.ref015","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1111\/jce.13046","article-title":"Catheter Ablation for Atrial Arrhythmias in Patients With Cardiac Amyloidosis","volume":"27","author":"NY Tan","year":"2016","journal-title":"J Cardiovasc Electrophysiol"},{"key":"pone.0301753.ref016","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/pace.13992","article-title":"Catheter ablation of atrial fibrillation in cardiac amyloidosis","volume":"43","author":"E Black-Maier","year":"2020","journal-title":"Pacing Clin Electrophysiol"},{"key":"pone.0301753.ref017","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/europace\/euz314","article-title":"Atrial fibrillation ablation in patients with transthyretin cardiac amyloidosis.","volume":"22","author":"E Donnellan","year":"2020","journal-title":"Europace"},{"key":"pone.0301753.ref018","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18\u201322 April 2004.","volume":"79","author":"MA Gertz","year":"2005","journal-title":"Am. J. Hematol"},{"key":"pone.0301753.ref019","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1136\/heartjnl-2012-302353","article-title":"Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis","volume":"98","author":"D Phelan","year":"2012","journal-title":"Heart"},{"key":"pone.0301753.ref020","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"JD Gillmore","year":"2016","journal-title":"Circulation"},{"key":"pone.0301753.ref021","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3109\/13506120208995243","article-title":"Electron and immuno-electron microscopy of abdominal fat identifies and characterizes amyloid fibrils in suspected cardiac amyloidosis","volume":"9","author":"E Arbustini","year":"2002","journal-title":"Amyloid"},{"key":"pone.0301753.ref022","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/europace\/eux274","article-title":"2017HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"20","author":"H Calkins","year":"2018","journal-title":"Europace"},{"key":"pone.0301753.ref023","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jchf.2017.05.001","article-title":"Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.","volume":"5","author":"U Sartipy","year":"2017","journal-title":"JACC Heart Fail"},{"key":"pone.0301753.ref024","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1056\/NEJMoa1113566","article-title":"Radiofrequency Ablation as Initial Therapy in Paroxysmal Atrial Fibrillation","volume":"367","author":"J Cosedis Nielsen","year":"2012","journal-title":"N Engl J Med"},{"key":"pone.0301753.ref025","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1161\/01.CIR.0000101684.88679.AB","article-title":"Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation","volume":"108","author":"O Wazni","year":"2003","journal-title":"Circulation"},{"key":"pone.0301753.ref026","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1161\/CIRCULATIONAHA.108.772582","article-title":"Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study","volume":"118","author":"P Ja\u00efs","year":"2008","journal-title":"Circulation"},{"key":"pone.0301753.ref027","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1056\/NEJMoa0708234","article-title":"Pulmonary-Vein Isolation for Atrial Fibrillation in Patients with Heart Failure","volume":"359","author":"MN Khan","year":"2008","journal-title":"N Engl J Med"},{"key":"pone.0301753.ref028","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.","volume":"42","author":"G Hindricks","year":"2021","journal-title":"Eur Heart J"},{"key":"pone.0301753.ref029","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1378\/chest.104.2.618","article-title":"Left ventricular systolic dysfunction precipitated by verapamil in cardiac amyloidosis.","volume":"104","author":"A Pollak","year":"1993","journal-title":"Chest"},{"key":"pone.0301753.ref030","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.acvd.2016.11.005","article-title":"The usefulness of global left atrial strain for predicting atrial fibrillation recurrence after catheter ablation in patients with persistent and paroxysmal atrial fibrillation.","volume":"110","author":"XX Ma","year":"2017","journal-title":"Arch. Cardiovasc. Dis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0301753","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,5]],"date-time":"2024-04-05T16:16:25Z","timestamp":1712333785000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0301753"}},"subtitle":[],"editor":[{"given":"Neil","family":"Patel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,4,5]]},"references-count":30,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0301753","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,5]]}}}